HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 80 filers reported holding HARROW HEALTH INC in Q1 2022. The put-call ratio across all filers is 5.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,773,410 | -26.2% | 193,000 | -2.2% | 0.07% | -25.6% |
| Q2 2023 | $3,758,496 | -25.2% | 197,400 | -16.9% | 0.09% | -32.3% |
| Q1 2023 | $5,027,616 | +25.6% | 237,600 | -12.4% | 0.13% | +27.9% |
| Q4 2022 | $4,001,436 | +4.9% | 271,100 | -14.2% | 0.10% | +2.0% |
| Q3 2022 | $3,815,000 | +63.9% | 316,100 | -1.2% | 0.10% | +92.5% |
| Q2 2022 | $2,328,000 | +9.2% | 319,800 | +2.3% | 0.05% | +29.3% |
| Q1 2022 | $2,132,000 | -5.3% | 312,600 | +19.9% | 0.04% | -2.4% |
| Q4 2021 | $2,252,000 | -6.4% | 260,700 | -1.5% | 0.04% | -8.7% |
| Q3 2021 | $2,406,000 | +89.0% | 264,712 | +93.2% | 0.05% | +100.0% |
| Q2 2021 | $1,273,000 | -17.7% | 137,000 | -40.2% | 0.02% | -20.7% |
| Q1 2021 | $1,546,000 | +65.2% | 229,000 | +67.9% | 0.03% | +45.0% |
| Q4 2020 | $936,000 | +335.3% | 136,400 | +216.5% | 0.02% | +566.7% |
| Q1 2019 | $215,000 | -12.2% | 43,100 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $245,000 | – | 43,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,065,416 | $21,029,000 | 2.75% |
| Diametric Capital, LP | 252,774 | $1,734,000 | 1.38% |
| Birchview Capital, LP | 180,000 | $1,235,000 | 0.71% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 118,389 | $812,000 | 0.61% |
| Zebra Capital Management LLC | 58,062 | $398,000 | 0.50% |
| Precision Wealth Strategies, LLC | 62,739 | $430,000 | 0.47% |
| Sio Capital Management, LLC | 209,623 | $1,438,000 | 0.29% |
| Uniplan Investment Counsel, Inc. | 505,746 | $3,469,000 | 0.24% |
| CORRADO ADVISORS, LLC | 31,580 | $217,000 | 0.17% |
| BARD ASSOCIATES INC | 287,250 | $1,970,000 | 0.16% |